Companies

Insight Molecular Diagnostics Inc. (IMDX) SEC filings

CIK 0001642380 · In Vitro & In Vivo Diagnostic Substances (SIC 2835) · Nasdaq · incorporated in CA · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)4.1 M1.5 M958000
Net income (USD)-72.9 M-64.1 M
Diluted EPS (USD/shares)-1.65-3.75-13.25

Latest filings

FiledFormDescriptionPeriod
2026-09-218-K8-K items 1.01,9.012026-09-15
2026-08-1010-Q10-Q2026-06-30
2026-08-108-K8-K items 2.02,7.01,8.01,9.012026-08-10
2026-07-24S-8S-8
2026-07-06442026-07-01
2026-07-06442026-07-01
2026-07-06442026-07-01
2026-06-178-K8-K items 5.02,5.07,9.012026-06-11
2026-06-15442026-06-11
2026-06-15442026-06-11
2026-06-15442026-06-11
2026-05-1310-Q10-Q2026-03-31
2026-05-138-K8-K items 2.02,9.012026-05-13
2026-05-138-K/A8-K/A items 8.012026-02-20
2026-04-30ARSARS2025-12-31
2026-04-30DEFA14ADEFA14A
2026-04-30DEF 14ADEF 14A2026-04-30
2026-04-308-K8-K items 8.01,9.012026-04-30
2026-04-27SCHEDULE 13D/ASCHEDULE 13D/A
2026-04-27442026-04-23
2026-04-20442026-04-16
2026-03-30442026-03-26
2026-03-30442026-03-26
2026-03-30442026-03-26
2026-03-2610-K10-K2025-12-31

Forms on file (last 1,000): 4 214, 8-K 178, 3 34, 10-Q 32, SC 13D/A 21, 424B5 19, UPLOAD 15, CORRESP 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=IMDX (0.002 USD), /gw/filings/filings?ticker=IMDX&form=8-K, /gw/filings/facts?ticker=IMDX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange